Jefferies Maintains Buy on Exact Sciences, Raises Price Target to $100
Portfolio Pulse from jenniferd'souza@benzinga.com
Jefferies analyst Brandon Couillard maintains a Buy rating on Exact Sciences (NASDAQ:EXAS) and raises the price target from $82 to $100.
June 07, 2023 | 3:12 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Jefferies analyst maintains Buy rating on Exact Sciences and raises price target from $82 to $100.
The news of Jefferies analyst maintaining a Buy rating and raising the price target for Exact Sciences (EXAS) from $82 to $100 is positive for the stock. This indicates that the analyst has a bullish outlook on the company's performance and expects the stock price to rise in the short term. As a result, this news is likely to have a positive impact on the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100